Lung Therapeutics

Lung Therapeutics

  • Founded: 2013
  • Location: Austin, TX
  • Employee range: 11 - 50
  • Clinical stage: Clin2
  • Therapy area: Loculated pleural effusion
  • Drug types: LNG, GEN
  • Lead product: LTI-01
  • Product link:
  • Funding: $36M C Jun 2019; $14M B Jul 2017

job board

Short description:

Respiratory Treatments

Drug notes:

Also RD/Clin0 malignant pleural effusion; LTI-03 Clin1 idiopathic pulmonary fibrosis; LTI-05 RD/Clin0 cystic fibrosis; LTI-07 RD/Clin0 fibrotic conditions

Long description:

Lung Therapeutics is developing medicines for unmet medical needs in fibrosis and lung disease.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy